Skip to main content

Table 2 Summary of HCMV-tetramer in HLA-A24 individual groups

From: Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses

Age(yr.) (n = 519) 0–4 (n = 202) 5–9 (n = 106) 10–14 (n = 108) 15–19 (n = 58) 20–29 (n = 45)
Number of tet(+) 39(19%) 32(30%) 23(21%) 24(41%) 15(33%)
CD8(%) 20.0 ± 5.7 18.6 ± 5.1 19.5 ± 6.9 22.3 ± 8.3 24.8 ± 6.4
Tet(%) 0.05 ± 0.07 0.02 ± 0.03 0.02 ± 0.01 0.04 ± 0.06 0.03 ± 0.03
Tet/CD8(%) 0.21 ± 0.31 0.12 ± 0.10 0.15 ± 0.24 0.14 ± 0.16 0.12 ± 0.10
  1. HCMV-tetramer positive: Tet/CD8(+) Lymphocytes ≥ 0.04%